Combination therapy comprising bridged tricyclic carbamoylpyridone compounds and p-glycoprotein inhibitors

TW202631140APending Publication Date: 2026-08-01GILEAD SCIENCES INC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-10-02
Publication Date
2026-08-01

Smart Images

  • Figure TWG2TA001070683_001
    Figure TWG2TA001070683_001
  • Figure TWG2TA001070683_002
    Figure TWG2TA001070683_002
  • Figure TWG2TA001070683_003
    Figure TWG2TA001070683_003
Patent Text Reader

Abstract

The present disclosure relates generally to combinations of compounds of Formula I or Formula II with a P-glycoprotein inhibitor. Also disclosed are pharmaceutical compositions comprising said combinations. The combinations of the disclosure are useful in treating or preventing human immunodeficiency virus (HIV) infection.
Need to check novelty before this filing date? Find Prior Art